Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?

被引：0
作者：
Michael S. Hofman
Rodney J. Hicks
机构：
[1] Centre for Cancer Imaging,Molecular Imaging
[2] Peter MacCallum Cancer Centre,Department of Medicine
[3] The University of Melbourne,Centre for Cancer Imaging
[4] Peter MacCallum Cancer Centre,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：211 / 213
页数：2
相关论文
共 50 条
[31]   A dosimetric comparison of systemic peptide receptor radionuclide therapy and intra-arterial peptide receptor radionuclide therapy in patients with liver dominant gastroenteropancreatic neuroendocrine tumours [J].
Nautiyal, Amit ;
Jha, Ashish K. ;
Konuparamban, Acsah ;
Mithun, Sneha ;
Srichandan, Tusharkanta ;
Puranik, Ameya ;
Gala, Kunal ;
Shetty, Nithin ;
Kulkarni, Suyash ;
Rangarajan, Venkatesh .
NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (07) :585-595
[32]   Current status of peptide receptor radionuclide therapy in grade 1 and 2 gastroenteropancreatic neuroendocrine tumours [J].
Kuiper, Jelka ;
Zoetelief, Eline ;
Brabander, Tessa ;
de Herder, Wouter W. ;
Hofland, Johannes .
JOURNAL OF NEUROENDOCRINOLOGY, 2025, 37 (03)
[33]   Real-world efficacy of lutetium peptide receptor radionuclide therapy in patients with neuroendocrine tumours [J].
Almeamar, Hussein ;
Cullen, Lisa ;
Murphy, David J. ;
Crowley, Rachel K. ;
Toumpanakis, Christos ;
Welin, Staffan ;
O'Shea, Donal ;
O'Toole, Dermot .
JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 (06)
[34]   Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review [J].
Daphne Merel Valerie Huizing ;
Berlinda Jantina de Wit-van der Veen ;
Marcel Verheij ;
Marcellus Petrus Maria Stokkel .
EJNMMI Research, 8
[35]   Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review [J].
Huizing, Daphne Merel Valerie ;
de Wit-van der Veen, Berlinda Jantina ;
Verheij, Marcel ;
Stokkel, Marcellus Petrus Maria .
EJNMMI RESEARCH, 2018, 8
[36]   Peptide receptor radionuclide therapy combinations for neuroendocrine tumours in ongoing clinical trials: status 2023 [J].
di Santo, Gianpaolo ;
Santo, Giulia ;
Sviridenko, Anna ;
Virgolini, Irene .
THERANOSTICS, 2024, 14 (03) :940-953
[37]   Peptidradiorezeptortherapie neuroendokriner TumorenPeptide receptor radionuclide therapy of neuroendocrine tumours [J].
A.R. Haug ;
P. Bartenstein .
Der Onkologe, 2011, 17 :602-608
[38]   Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors [J].
Kwekkeboom, Dik J. ;
Krenning, Eric P. .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (01) :179-+
[39]   Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors [J].
Bodei, Lisa ;
Cremonesi, Marta ;
Kidd, Mark ;
Grana, Chiara M. ;
Severi, Stefano ;
Modlin, Irvin M. ;
Paganelli, Giovanni .
THORACIC SURGERY CLINICS, 2014, 24 (03) :333-+
[40]   Cure of Neuroendocrine Carcinoma by Peptide Receptor Radionuclide Therapy [J].
Zoephel, Klaus ;
Strumpf, Annette ;
Wunderlich, Gerd ;
Oehme, Liane ;
Eisenhofer, Graeme ;
Kotzerke, Joerg .
CLINICAL NUCLEAR MEDICINE, 2008, 33 (10) :690-691
12345